The increase in cash flow from investing activities and the corresponding decrease to cash flow from operating activities upon adoption of the standard was $96.8 million and $596.1 million for the three months ended November 30, 2018 and 2017, respectively.
Includes $4.4 million and $5.9 million recorded in the EMS segment, $1.6 million and $4.6 million recorded to the DMS segment and $0.0 million and $0.9 million of non-allocated charges for the three months ended November 30, 2018 and 2017, respectively.
The Company is party to certain lawsuits in the ordinary course of business.
The amount for the three months ended November 30, 2018 was primarily classified as a component of cost of revenue.
The Company procures components from a broad group of suppliers.
The remaining amount for the three months ended November 30, 2017 was primarily classified as a component of cost of revenue.
In addition, the beneficial interest of $162.2 million and $747.3 million for the three months ended November 30, 2018 and 2017, respectively, obtained in exchange for securitized receivables are reported as non-cash investing activities.
Item 1A.
The Company is one of the leading providers of worldwide manufacturing services and solutions.
Amortization of $15.5 million and no impairment costs related to fulfillments costs were recognized during the three months ended November 30, 2018.
For the three months ended November 30, 2018 and 2017, the amount represented proceeds from collections reinvested in revolving-period transfers.
For the three months ended November 30, 2017, the amounts were immaterial and were recognized as components of cost of revenue.During the three months ended August 31, 2018 and May 31, 2018, the decrease in days in inventory from the prior sequential quarter was primarily due to increased sales activity during the quarter.
During the three months ended May 31, 2018, the decrease in days in accounts payable from the prior sequential quarter was primarily due to the timing of purchases and cash payments for purchases during the quarter.
Selling, general and administrative expenses decreased during the three months ended November 30, 2018, compared to the three months ended November 30, 2017.
During the three months ended November 30, 2018, days in inventory increased from the prior sequential quarter to support expected sales levels in the second quarter of fiscal year 2019.
Research and development expenses remained consistent as a percentage of net revenue during the three months ended November 30, 2018, compared to the three months ended November 30, 2017.
Specifically, the DMS segment revenues increased 10% due to (i) a 6% increase in revenues from customers within our mobility business as a result of increased end user product demand and (ii) a 4% increase in revenues from existing customers in our healthcare business.Item 1.